Stan Polovets is the co-founder and chairman of The Genesis Prize Foundation (GPF). He also co-founded and led Genesis Philanthropy Group (GPG) for the first seven years since its inception in 2007.
In May 2020, Mr. Polovets was elected Chairman of the Board of a NASDAQ-listed biopharmaceutical company, Anchiano Therapeutics Ltd., dedicated to the discovery and development of cancer treatments. He previously served as CEO of the Alfa-Access-Renova (AAR) Consortium, a private equity firm with a global energy portfolio valued in excess of $25 billion.
Mr. Polovets represented TNK in its merger with BP to form one of the world’s largest oil companies and in the eventual sale of the merged company TNK-BP for $55 billion. Mr. Polovets also held management, advisory, M&A and various financial positions at ExxonMobil, KPMG, EY and The RAND Corporation.
Mr. Polovets served as lead non-executive director of Clal Industries and of L1 Energy, lead independent director at Taavura and Nesher, member of the Board of Overseers at Stanford University’s Hoover Institution, Chairman for Eastern Europe at Edelman, and director at oil companies Slavneft and TNK-BP. He currently serves as a member of the Board of Overseers of New York University (NYU) Tandon School of Engineering, NYU President’s Global Council, and the Council on Foreign Relations.
In 2006, Mr. Polovets founded and served as the chairman of the Vnimanie Foundation, a non-profit organization dedicated to supporting Russian children with learning disabilities and behavioral disorders.
Mr. Polovets is a graduate of Stanford Business School and has a Master’s Degree from Stanford University in Russian and East European Studies.